From the floor in Shanghai: 8 posters, one theme
Reported from the sessions, and from the two hours afterwards.
The archive
Page 91 of 170 of this archive, newest first.
Independent analysis puts a HJ exenatide lot at 98.4%, against 97.3% on the certificate
The report states the gradient, the wavelength and the integration threshold, which is more than most.
Three services, one lot, and a spread of two and a half points
Duplicate submissions under different names test within-laboratory repeatability, which is a different quantity from between-laboratory reproducibility.
The 0.22 micron filter does the work, and it is the last line
Bioburden entering the filter, filter integrity, environmental monitoring and aseptic process simulation are the four pillars. The trade documents none of them.
Inspectors cite the consolidator trading as Meridian Freight Partners over sterility assurance
The observation that closes a facility is rarely the dramatic one.
The 28-day notice: how a compounding wind-down works in Canada
The document is four pages. Three of them are about dates.
VendorInvestigate result on a Hong Kong retatrutide lot lands 2.9 points below the supplier’s figure
A reminder that a purity figure is the output of a method, and that methods differ.
Sarcopenia is a diagnosis, not a synonym for losing lean mass
Almost every practical recommendation in circulation was established in a population that does not resemble the people now following it.
Side effects, cost, supply, target: four reasons with four trajectories
Real-world persistence figures, with their definitions stated, because the definitions are doing most of the work.
Halvard & Pike Apothecary of Portland, Maine enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
Japan pharmacy body issues counselling standards for exenatide initiation
The evidence base is thin and the document says so, which is to its credit.
Changsha export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
Independent analysis puts a MKM liraglutide lot at 96.2%, against 94.9% on the certificate
The Journal submitted the sample and paid for the analysis. The vendor was told in advance.
The shortage years, and what they taught about interruption
The trials studied planned withdrawal. Almost nobody stops that way.
Tapering: a word borrowed from drugs with withdrawal syndromes
What a slow reduction could plausibly buy, and what it certainly cannot prevent.
Why a dead-clean sterile filter can pass pyrogen straight through
Three compendial method families are in routine use and a fourth, based on a recombinant enzyme rather than crab lysate, is now compendial in its own right.
From the floor in Hangzhou: 24 posters, one theme
Reported from the sessions, and from the two hours afterwards.
Why summer is a documented quality problem in this trade
The route did not close because of a rule about peptides.
SURPASS-2 extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
PeptideMeter result on a Hangzhou exenatide lot lands 3.5 points below the supplier’s figure
The result is unremarkable. What the report omits is not.
Five things a purity figure cannot tell you
An orthogonal method separates on a different physical principle, so that species co-eluting in the first are likely to resolve in the second. Two runs of the same method at…
From the floor in Nantong: 3 posters, one theme
Reported from the sessions, and from the two hours afterwards.
What the new Australia guidance says about stopping
The evidence base is thin and the document says so, which is to its credit.
SURMOUNT-2 misses on a secondary endpoint the coverage has not mentioned
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Independent analysis puts a WWB exenatide lot at 98.5%, against 96.6% on the certificate
The result is unremarkable. What the report omits is not.
What we would need to randomise to answer this properly
One randomised trial has combined a GLP-1 receptor agonist with supervised exercise. Its result is the single most useful piece of evidence in this area.
Why people actually stop, in the order they actually stop
Why the reason for stopping changes what happens afterwards.
The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
A shortage listing ends. 22 pharmacies now have a business model and no legal basis for it.
The document is four pages. Three of them are about dates.
What a 15% rise in coupling-reagent prices does to a 20 mg vial
Follow the resin, not the catalogue.